A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma.
about
Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma.Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience.Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysisEfficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study
P2860
A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A retrospective paired study: ...... y in nasopharyngeal carcinoma.
@ast
A retrospective paired study: ...... y in nasopharyngeal carcinoma.
@en
type
label
A retrospective paired study: ...... y in nasopharyngeal carcinoma.
@ast
A retrospective paired study: ...... y in nasopharyngeal carcinoma.
@en
prefLabel
A retrospective paired study: ...... y in nasopharyngeal carcinoma.
@ast
A retrospective paired study: ...... y in nasopharyngeal carcinoma.
@en
P2093
P2860
P1433
P1476
A retrospective paired study: ...... y in nasopharyngeal carcinoma.
@en
P2093
P2860
P2888
P356
10.1186/S12885-016-2974-X
P407
P577
2016-12-13T00:00:00Z
P6179
1039416078